TAM JAI INTL(02217) mid-term profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.

12:36 14/11/2024

Tanzi International (02217) announced that for the six months ended September 30, 2024, it achieved revenue of 1.404 billion...

TAM JAI INTL (02217) announced that, for the six months ended September 30, 2024, the company achieved revenue of 1.404 billion Hong Kong dollars, an increase of 1.23% year-on-year; the net profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.

PetroChina's controlling shareholder and its subsidiaries have cumulatively increased their holdings in the company by 0.17%.

Gan & Lee Pharmaceuticals subsidiary obtains registration approval for sitagliptin metformin tablets (II) drug.

Estun Automation (002747.SZ): The company's H shares have been included in the list of securities eligible for trading under the Hong Kong Stock Connect.

PetroChina's controlling shareholder and its subsidiaries have cumulatively increased their holdings in the company by 0.17%.

Gan & Lee Pharmaceuticals subsidiary obtains registration approval for sitagliptin metformin tablets (II) drug.

Estun Automation (002747.SZ): The company's H shares have been included in the list of securities eligible for trading under the Hong Kong Stock Connect.